An open science pathway for drug marketing authorization-Registered drug approval.
Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-08-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.1003726 |